Blood cells from people with MS showed weaker activity linked to calming immune responses.
Researchers studied how an immune signal helps blood cells develop the ability to calm immune responses. Another signal inside these cells was needed for that change. The researchers also found this pattern in blood cells from healthy people. In people with MS, the pattern was altered. Their blood cells were less able to develop this calming role in lab tests, and fewer such cells were found in their blood.
The study examined blood cells from people with MS and healthy people. It also included lab tests using human cells. The findings concern cells that help keep immune responses in check. The MS group showed changes in both cell activity and the number of these cells in their blood. This was research into how cells work, not a test of an MS treatment.
The abstract does not say how many people took part. You cannot tell from this study whether these cell changes cause MS. It does not show whether changing these signals would help people with MS.
AI-generated summary — for informational purposes only, not medical advice
11/1/2026
Researchers compared blood from people with childhood-onset MS and healthy volunteers. They found DN
Read More11/1/2026
In 24 people with severe MS, stem cell treatment lowered signs of inflammation and nerve damage for
Read More11/1/2026
A review of 49 studies finds special brain scans can detect MS-related inflammation, but scan method
Read More10/6/2026
Researchers found immune cells that swap surface tags in MS. An MS treatment removed them in the stu
Read More10/6/2026
In children with MS, immune attacks on the brain and spinal cord may go unchecked. See what research
Read More10/1/2026
A study links a body chemical to MS inflammation and shows that blocking its source eases symptoms i
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Cell reports often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.